“Deucravacitinib in Plaque Psoriasis: 2-Year Laboratory Results from the Phase 3 POETYK PSO Program”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 2, Mar. 2023, p. s119, https://doi.org/10.25251/skin.7.supp.119.